Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Monsanto House of the Future Monsanto House of the Future The Monsanto House of the Future was an attraction at Disneyland's Tomorrowland. in Anaheim, California, USA, from 1957 to 1967. Sponsored by Monsanto Company, the House of the Future was made possible by Monsanto, the Massachusetts Institute of Technology (MIT), and Walt Disney Imagineering. With this project, Monsanto wanted to demonstrate plastics' versatility as a high-quality, engineered material. The design team for this innovative structure included MIT architecture faculty Richard Hamilton and Marvin Goody (founders of Goody Clancy) and MIT civil engineering faculty Albert G. H. Dietz , Frank J. Heger, Jr. (a founder of